Sweet's Syndrome: Systemic Signs and Symptoms and Associated Disorders
Section snippets
METHODS
We retrospectively reviewed the Mayo Clinic medical records for 1980 through 1992 to find diagnoses of definite or possible SS. For the 63 cases identified, all historical data and histologic slides were thoroughly reviewed.
Fifteen of the 63 cases were excluded for the following reasons: (1) no lesions were present at the time of initial assessment at the Mayo Clinic (8 cases), (2) the histopathologic findings did not support the diagnosis (6 cases), and (3) few clinical features existed to
Results
The study group consisted of 28 women and 20 men. The age range was 26 to 79 years (mean ages, 56 in women and 58 in men).
The predominant lesions at the time of initial examination were multiple tender or painful erythematous or violaceous plaques (58%) or nodules (27%) of acute onset (Fig. 1). Vesicles or bullae, papules, urticarial lesions, pustules, ulcers, purpura, or hemorrhagic lesions (Fig. 2) were also noted. These less typical lesions were found in 26 of our patients, 14 of whom had a
DISCUSSION
Since the first description of SS, it has been recognized in numerous clinical settings. The spectrum of associated conditions reported in the world literature includes infections, hematopoietic or lymphoid disorders and malignant diseases, solid tumors, paraproteinemias, rheumatologic disease, inflammatory bowel disease, pregnancy, drug associations, and other systemic disorders.2, 3, 4, 5, 6, 7, 8, 9 Pathergy has also been previously noted in patients with SS.4, 9, 10 The patients in our
CONCLUSION
SS has been reported to occur in conjunction with infections, hematopoietic, lymphoid, and plasma cell disorders, malignant disease, and many other systemic conditions.2, 3, 4, 5, 6, 7, 8, 9 In light of the currently available information about SS, thorough assessment of patients with new-onset SS is imperative, especially when it occurs in combination with oral lesions, anemia, or a platelet count abnormality. Such an assessment should include a complete history and physical examination,
REFERENCES (34)
- et al.
Sweet's syndrome; a clinico-pathologic review of twenty-nine cases
J Am Acad Dermatol
(1990) - et al.
Sweet's syndrome and pregnancy
J Am Acad Dermatol
(1994) - et al.
Sweet's syndrome and cancer
Clin Dermatol
(1993 Jan-Mar) - et al.
Neutrophilic dermatoses and myeloproliferative disease: report of two cases
Mayo Clin Proc
(1985) - et al.
Increased plasma chemoattractant in Sweet's syndrome
J Am Acad Dermatol
(1985) - et al.
IgA-associatcd inhibition of polymorphonuclear leukocyte chemolaxis in neutrophilic dermatoses
J Invest Dermatol
(1981) - et al.
Neutrophilic dermatosis of myeloproliferative disorders: atypical forms of pyoderma gangrenosum and Sweet's syndrome associated with myeloproliferative disorders
J Am Acad Dermatol
(1983) - et al.
Antibodies to neutrophil cytoplasmic antigens: serologic marker for Sweet's syndrome
J Am Acad Dermatol
(1991) An acute febrile neutrophilic dermatosis
Br J Dermatol
(1964)- et al.
Acute febrile neutrophilic dermatosis (Sweet's syndrome) and myeloproliferative disorders
Cancer
(1983)
Malignancy-associated Sweet's syndrome; review of the world literature
J Clin Oncol
Sweet syndrome in patients with solid tumors
Cancer
Sweet's syndrome and mediastinal lymph-adenopathy due to sarcoidosis: three cases of a new association [letter J
Arch Dermatol
Acute febrile neutrophilic dermatosis (Sweet's syndrome)
Int J Dermatol
Diagnostic criteria for Sweet's syndrome
Cutis
Sweet's syndrome; clinical spectrum and associated conditions
Cutis
Myelofibrosis discovered after diagnosis of Sweet's syndrome
Int J Dermatol
Cited by (190)
Pediatric Neutrophilic Dermatoses
2024, Dermatologic ClinicsSweet Syndrome and Neutrophilic Dermatosis of the Dorsal Hands
2024, Dermatologic ClinicsSweet syndrome with osseous and splenic involvement: A case report
2022, Radiology Case ReportsWhitcup and Nussenblatt’s Uveitis: Fundamentals and Clinical Practice
2021, Whitcup and Nussenblatt's Uveitis: Fundamentals and Clinical PracticeSystemic Corticosteroids
2020, Comprehensive Dermatologic Drug Therapy, Fourth EditionCorticosteroid-resistant Sweet's syndrome as the first manifestation of myelodysplastic/ myeloproliferative neoplasm-unclassifiable: A case report
2022, Emergency and Critical Care Medicine